nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—HTR7—coronary artery disease	0.136	0.471	CbGaD
Perphenazine—CYP2C19—coronary artery disease	0.0844	0.292	CbGaD
Perphenazine—HTR2A—coronary artery disease	0.0684	0.237	CbGaD
Perphenazine—HTR1A—Penbutolol—coronary artery disease	0.0237	0.0579	CbGbCtD
Perphenazine—CYP2C8—Fenofibrate—coronary artery disease	0.017	0.0417	CbGbCtD
Perphenazine—CYP2B6—Clopidogrel—coronary artery disease	0.0156	0.0381	CbGbCtD
Perphenazine—CYP2C8—Gemfibrozil—coronary artery disease	0.0136	0.0333	CbGbCtD
Perphenazine—CYP2C9—Fenofibrate—coronary artery disease	0.0119	0.0291	CbGbCtD
Perphenazine—CYP2C8—Clopidogrel—coronary artery disease	0.0118	0.0289	CbGbCtD
Perphenazine—CYP2C19—Gemfibrozil—coronary artery disease	0.0114	0.0279	CbGbCtD
Perphenazine—CYP1A2—Gemfibrozil—coronary artery disease	0.0105	0.0258	CbGbCtD
Perphenazine—CYP2C8—Pitavastatin—coronary artery disease	0.0103	0.0252	CbGbCtD
Perphenazine—CYP2C19—Clopidogrel—coronary artery disease	0.00991	0.0242	CbGbCtD
Perphenazine—CYP2C9—Gemfibrozil—coronary artery disease	0.0095	0.0232	CbGbCtD
Perphenazine—CYP2B6—Simvastatin—coronary artery disease	0.00934	0.0228	CbGbCtD
Perphenazine—CYP1A2—Clopidogrel—coronary artery disease	0.00914	0.0224	CbGbCtD
Perphenazine—CYP2C19—Telmisartan—coronary artery disease	0.00866	0.0212	CbGbCtD
Perphenazine—CYP2B6—Atorvastatin—coronary artery disease	0.00833	0.0204	CbGbCtD
Perphenazine—CYP2C9—Clopidogrel—coronary artery disease	0.00824	0.0201	CbGbCtD
Perphenazine—CYP3A4—Ticagrelor—coronary artery disease	0.00775	0.019	CbGbCtD
Perphenazine—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00742	0.0181	CbGbCtD
Perphenazine—CYP2C9—Pitavastatin—coronary artery disease	0.0072	0.0176	CbGbCtD
Perphenazine—CYP2C8—Simvastatin—coronary artery disease	0.00708	0.0173	CbGbCtD
Perphenazine—CYP2C9—Valsartan—coronary artery disease	0.00701	0.0171	CbGbCtD
Perphenazine—CYP2C19—Timolol—coronary artery disease	0.00698	0.0171	CbGbCtD
Perphenazine—CYP2C8—Lovastatin—coronary artery disease	0.00692	0.0169	CbGbCtD
Perphenazine—CYP2C8—Pravastatin—coronary artery disease	0.00692	0.0169	CbGbCtD
Perphenazine—CYP3A4—Fenofibrate—coronary artery disease	0.00691	0.0169	CbGbCtD
Perphenazine—CYP2C19—Rosuvastatin—coronary artery disease	0.00639	0.0156	CbGbCtD
Perphenazine—CYP2C8—Atorvastatin—coronary artery disease	0.00631	0.0154	CbGbCtD
Perphenazine—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00622	0.0152	CbGbCtD
Perphenazine—CYP2C19—Simvastatin—coronary artery disease	0.00594	0.0145	CbGbCtD
Perphenazine—CYP2C19—Lovastatin—coronary artery disease	0.00581	0.0142	CbGbCtD
Perphenazine—CYP2C8—Losartan—coronary artery disease	0.00577	0.0141	CbGbCtD
Perphenazine—CYP2D6—Niacin—coronary artery disease	0.00571	0.014	CbGbCtD
Perphenazine—CYP3A4—Gemfibrozil—coronary artery disease	0.00553	0.0135	CbGbCtD
Perphenazine—CYP2C9—Rosuvastatin—coronary artery disease	0.00531	0.013	CbGbCtD
Perphenazine—CYP2D6—Timolol—coronary artery disease	0.00531	0.013	CbGbCtD
Perphenazine—CYP2C19—Atorvastatin—coronary artery disease	0.00529	0.0129	CbGbCtD
Perphenazine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00517	0.0126	CbGbCtD
Perphenazine—CYP2C9—Simvastatin—coronary artery disease	0.00494	0.0121	CbGbCtD
Perphenazine—CYP2C19—Losartan—coronary artery disease	0.00484	0.0118	CbGbCtD
Perphenazine—CYP2C9—Lovastatin—coronary artery disease	0.00483	0.0118	CbGbCtD
Perphenazine—CYP2C9—Pravastatin—coronary artery disease	0.00483	0.0118	CbGbCtD
Perphenazine—CYP3A4—Clopidogrel—coronary artery disease	0.00479	0.0117	CbGbCtD
Perphenazine—CYP2D6—Captopril—coronary artery disease	0.00467	0.0114	CbGbCtD
Perphenazine—CYP2D6—Simvastatin—coronary artery disease	0.00451	0.011	CbGbCtD
Perphenazine—CYP1A2—Losartan—coronary artery disease	0.00447	0.0109	CbGbCtD
Perphenazine—CYP3A4—Eplerenone—coronary artery disease	0.00445	0.0109	CbGbCtD
Perphenazine—CYP2D6—Pravastatin—coronary artery disease	0.00442	0.0108	CbGbCtD
Perphenazine—CYP2D6—Lovastatin—coronary artery disease	0.00442	0.0108	CbGbCtD
Perphenazine—CYP2C9—Atorvastatin—coronary artery disease	0.0044	0.0108	CbGbCtD
Perphenazine—CYP2C9—cardial valve—coronary artery disease	0.00409	0.0965	CbGeAlD
Perphenazine—CYP2C9—Losartan—coronary artery disease	0.00402	0.00983	CbGbCtD
Perphenazine—CYP2D6—Atorvastatin—coronary artery disease	0.00402	0.00983	CbGbCtD
Perphenazine—CYP3A4—Enalapril—coronary artery disease	0.00397	0.0097	CbGbCtD
Perphenazine—CYP3A4—Rosuvastatin—coronary artery disease	0.00309	0.00755	CbGbCtD
Perphenazine—CYP3A4—Ezetimibe—coronary artery disease	0.00309	0.00755	CbGbCtD
Perphenazine—CYP3A4—Simvastatin—coronary artery disease	0.00287	0.00702	CbGbCtD
Perphenazine—CYP3A4—Pravastatin—coronary artery disease	0.00281	0.00686	CbGbCtD
Perphenazine—CYP3A4—Lovastatin—coronary artery disease	0.00281	0.00686	CbGbCtD
Perphenazine—CYP3A4—Atorvastatin—coronary artery disease	0.00256	0.00625	CbGbCtD
Perphenazine—CYP3A4—Losartan—coronary artery disease	0.00234	0.00572	CbGbCtD
Perphenazine—HTR7—pulmonary artery—coronary artery disease	0.00219	0.0516	CbGeAlD
Perphenazine—CALM1—sympathetic nervous system—coronary artery disease	0.00218	0.0513	CbGeAlD
Perphenazine—HTR7—sympathetic nervous system—coronary artery disease	0.00213	0.0502	CbGeAlD
Perphenazine—HTR2A—arteriole—coronary artery disease	0.00208	0.0491	CbGeAlD
Perphenazine—HTR7—vagus nerve—coronary artery disease	0.00206	0.0486	CbGeAlD
Perphenazine—HTR7—vein—coronary artery disease	0.00199	0.0469	CbGeAlD
Perphenazine—CALM1—autonomic nervous system—coronary artery disease	0.00146	0.0345	CbGeAlD
Perphenazine—HTR7—autonomic nervous system—coronary artery disease	0.00143	0.0337	CbGeAlD
Perphenazine—HTR2A—pulmonary artery—coronary artery disease	0.00136	0.0322	CbGeAlD
Perphenazine—HTR2A—sympathetic nervous system—coronary artery disease	0.00133	0.0313	CbGeAlD
Perphenazine—HTR2A—vagus nerve—coronary artery disease	0.00128	0.0303	CbGeAlD
Perphenazine—HTR2A—vein—coronary artery disease	0.00124	0.0293	CbGeAlD
Perphenazine—HTR2A—autonomic nervous system—coronary artery disease	0.000891	0.021	CbGeAlD
Perphenazine—CALM2—artery—coronary artery disease	0.000833	0.0197	CbGeAlD
Perphenazine—CALM1—artery—coronary artery disease	0.000829	0.0196	CbGeAlD
Perphenazine—HTR7—artery—coronary artery disease	0.00081	0.0191	CbGeAlD
Perphenazine—CALM2—endothelium—coronary artery disease	0.000704	0.0166	CbGeAlD
Perphenazine—CALM1—endothelium—coronary artery disease	0.0007	0.0165	CbGeAlD
Perphenazine—HTR7—endothelium—coronary artery disease	0.000684	0.0162	CbGeAlD
Perphenazine—CALM3—cardiac ventricle—coronary artery disease	0.000595	0.014	CbGeAlD
Perphenazine—CALM3—myocardium—coronary artery disease	0.00056	0.0132	CbGeAlD
Perphenazine—HTR2A—artery—coronary artery disease	0.000505	0.0119	CbGeAlD
Perphenazine—CALM2—cardiac ventricle—coronary artery disease	0.000467	0.011	CbGeAlD
Perphenazine—CALM1—cardiac ventricle—coronary artery disease	0.000465	0.011	CbGeAlD
Perphenazine—CALM2—myocardium—coronary artery disease	0.00044	0.0104	CbGeAlD
Perphenazine—CALM1—myocardium—coronary artery disease	0.000438	0.0103	CbGeAlD
Perphenazine—AOX1—heart—coronary artery disease	0.000434	0.0102	CbGeAlD
Perphenazine—HTR2A—endothelium—coronary artery disease	0.000427	0.0101	CbGeAlD
Perphenazine—CALM3—heart—coronary artery disease	0.000391	0.00922	CbGeAlD
Perphenazine—AOX1—cardiac atrium—coronary artery disease	0.000371	0.00876	CbGeAlD
Perphenazine—CALM3—cardiac atrium—coronary artery disease	0.000334	0.00789	CbGeAlD
Perphenazine—CALM2—heart—coronary artery disease	0.000307	0.00724	CbGeAlD
Perphenazine—CALM1—heart—coronary artery disease	0.000305	0.00721	CbGeAlD
Perphenazine—HTR7—heart—coronary artery disease	0.000298	0.00704	CbGeAlD
Perphenazine—HTR1A—cardiovascular system—coronary artery disease	0.000295	0.00695	CbGeAlD
Perphenazine—CALM3—blood—coronary artery disease	0.000292	0.00688	CbGeAlD
Perphenazine—CALM2—cardiovascular system—coronary artery disease	0.00029	0.00683	CbGeAlD
Perphenazine—CALM1—cardiovascular system—coronary artery disease	0.000288	0.0068	CbGeAlD
Perphenazine—HTR7—cardiovascular system—coronary artery disease	0.000282	0.00664	CbGeAlD
Perphenazine—CALM2—cardiac atrium—coronary artery disease	0.000262	0.00619	CbGeAlD
Perphenazine—CALM1—cardiac atrium—coronary artery disease	0.000261	0.00616	CbGeAlD
Perphenazine—Clomipramine—HRH2—coronary artery disease	0.000232	0.105	CrCbGaD
Perphenazine—CALM2—blood—coronary artery disease	0.000229	0.0054	CbGeAlD
Perphenazine—CYP2B6—heart—coronary artery disease	0.000228	0.00538	CbGeAlD
Perphenazine—CALM1—blood—coronary artery disease	0.000228	0.00538	CbGeAlD
Perphenazine—CYP2C9—heart—coronary artery disease	0.000226	0.00533	CbGeAlD
Perphenazine—HTR7—blood—coronary artery disease	0.000223	0.00525	CbGeAlD
Perphenazine—ADRA2A—heart—coronary artery disease	0.000219	0.00516	CbGeAlD
Perphenazine—CYP2C19—blood—coronary artery disease	0.000217	0.00513	CbGeAlD
Perphenazine—CYP2B6—cardiovascular system—coronary artery disease	0.000215	0.00508	CbGeAlD
Perphenazine—CYP2C9—cardiovascular system—coronary artery disease	0.000213	0.00503	CbGeAlD
Perphenazine—CYP2C8—blood—coronary artery disease	0.00019	0.00448	CbGeAlD
Perphenazine—ADRA2A—cardiac atrium—coronary artery disease	0.000187	0.00442	CbGeAlD
Perphenazine—HTR2A—heart—coronary artery disease	0.000186	0.00439	CbGeAlD
Perphenazine—CYP1A2—blood—coronary artery disease	0.000178	0.00419	CbGeAlD
Perphenazine—HTR2A—cardiovascular system—coronary artery disease	0.000176	0.00414	CbGeAlD
Perphenazine—CYP2B6—blood—coronary artery disease	0.00017	0.00402	CbGeAlD
Perphenazine—CYP2C9—blood—coronary artery disease	0.000169	0.00398	CbGeAlD
Perphenazine—ADRA2A—blood—coronary artery disease	0.000163	0.00385	CbGeAlD
Perphenazine—HTR2A—blood—coronary artery disease	0.000139	0.00328	CbGeAlD
Perphenazine—CYP3A4—blood—coronary artery disease	0.000129	0.00303	CbGeAlD
Perphenazine—CYP2D6—blood—coronary artery disease	0.000126	0.00299	CbGeAlD
Perphenazine—Aripiprazole—HTR7—coronary artery disease	0.000107	0.0485	CrCbGaD
Perphenazine—Flupentixol—HTR2A—coronary artery disease	0.000104	0.047	CrCbGaD
Perphenazine—Clomipramine—GSTP1—coronary artery disease	9.65e-05	0.0437	CrCbGaD
Perphenazine—Aripiprazole—ADRB1—coronary artery disease	9.19e-05	0.0416	CrCbGaD
Perphenazine—Cyamemazine—HTR2A—coronary artery disease	8.14e-05	0.0368	CrCbGaD
Perphenazine—Hypotension—Telmisartan—coronary artery disease	7.89e-05	0.000584	CcSEcCtD
Perphenazine—Constipation—Olmesartan—coronary artery disease	7.87e-05	0.000583	CcSEcCtD
Perphenazine—Pain—Olmesartan—coronary artery disease	7.87e-05	0.000583	CcSEcCtD
Perphenazine—Erythema—Ramipril—coronary artery disease	7.86e-05	0.000582	CcSEcCtD
Perphenazine—Shock—Perindopril—coronary artery disease	7.85e-05	0.000581	CcSEcCtD
Perphenazine—Anorexia—Captopril—coronary artery disease	7.83e-05	0.00058	CcSEcCtD
Perphenazine—Decreased appetite—Niacin—coronary artery disease	7.82e-05	0.000579	CcSEcCtD
Perphenazine—Confusional state—Furosemide—coronary artery disease	7.82e-05	0.000579	CcSEcCtD
Perphenazine—Tachycardia—Perindopril—coronary artery disease	7.78e-05	0.000576	CcSEcCtD
Perphenazine—Urticaria—Simvastatin—coronary artery disease	7.78e-05	0.000576	CcSEcCtD
Perphenazine—Insomnia—Trandolapril—coronary artery disease	7.78e-05	0.000576	CcSEcCtD
Perphenazine—Hypersensitivity—Clopidogrel—coronary artery disease	7.77e-05	0.000575	CcSEcCtD
Perphenazine—Anaphylactic shock—Furosemide—coronary artery disease	7.75e-05	0.000574	CcSEcCtD
Perphenazine—Insomnia—Enalapril—coronary artery disease	7.75e-05	0.000573	CcSEcCtD
Perphenazine—Body temperature increased—Simvastatin—coronary artery disease	7.74e-05	0.000573	CcSEcCtD
Perphenazine—Headache—Rosuvastatin—coronary artery disease	7.74e-05	0.000573	CcSEcCtD
Perphenazine—Hypersensitivity—Lovastatin—coronary artery disease	7.71e-05	0.000571	CcSEcCtD
Perphenazine—Decreased appetite—Pravastatin—coronary artery disease	7.7e-05	0.00057	CcSEcCtD
Perphenazine—Pain—Niacin—coronary artery disease	7.69e-05	0.000569	CcSEcCtD
Perphenazine—Erythema—Timolol—coronary artery disease	7.68e-05	0.000569	CcSEcCtD
Perphenazine—Hypotension—Captopril—coronary artery disease	7.68e-05	0.000568	CcSEcCtD
Perphenazine—Dyspnoea—Trandolapril—coronary artery disease	7.67e-05	0.000567	CcSEcCtD
Perphenazine—Somnolence—Trandolapril—coronary artery disease	7.64e-05	0.000566	CcSEcCtD
Perphenazine—Insomnia—Telmisartan—coronary artery disease	7.64e-05	0.000566	CcSEcCtD
Perphenazine—Dyspnoea—Enalapril—coronary artery disease	7.64e-05	0.000565	CcSEcCtD
Perphenazine—Dry mouth—Losartan—coronary artery disease	7.63e-05	0.000565	CcSEcCtD
Perphenazine—Shock—Furosemide—coronary artery disease	7.63e-05	0.000565	CcSEcCtD
Perphenazine—Somnolence—Enalapril—coronary artery disease	7.61e-05	0.000564	CcSEcCtD
Perphenazine—Anorexia—Perindopril—coronary artery disease	7.6e-05	0.000563	CcSEcCtD
Perphenazine—Pruritus—Fenofibrate—coronary artery disease	7.59e-05	0.000562	CcSEcCtD
Perphenazine—Constipation—Pravastatin—coronary artery disease	7.57e-05	0.00056	CcSEcCtD
Perphenazine—Pain—Pravastatin—coronary artery disease	7.57e-05	0.00056	CcSEcCtD
Perphenazine—Hypersensitivity—Ezetimibe—coronary artery disease	7.57e-05	0.00056	CcSEcCtD
Perphenazine—Muscle spasms—Ramipril—coronary artery disease	7.56e-05	0.000559	CcSEcCtD
Perphenazine—Confusional state—Losartan—coronary artery disease	7.54e-05	0.000558	CcSEcCtD
Perphenazine—Dyspnoea—Telmisartan—coronary artery disease	7.53e-05	0.000557	CcSEcCtD
Perphenazine—Somnolence—Telmisartan—coronary artery disease	7.51e-05	0.000556	CcSEcCtD
Perphenazine—Anaphylactic shock—Losartan—coronary artery disease	7.48e-05	0.000554	CcSEcCtD
Perphenazine—Decreased appetite—Trandolapril—coronary artery disease	7.48e-05	0.000553	CcSEcCtD
Perphenazine—Pruritus—Clopidogrel—coronary artery disease	7.46e-05	0.000552	CcSEcCtD
Perphenazine—Hypotension—Perindopril—coronary artery disease	7.45e-05	0.000552	CcSEcCtD
Perphenazine—Thioridazine—HTR7—coronary artery disease	7.45e-05	0.0337	CrCbGaD
Perphenazine—Decreased appetite—Enalapril—coronary artery disease	7.45e-05	0.000551	CcSEcCtD
Perphenazine—Infection—Losartan—coronary artery disease	7.43e-05	0.00055	CcSEcCtD
Perphenazine—Insomnia—Captopril—coronary artery disease	7.43e-05	0.00055	CcSEcCtD
Perphenazine—Pruritus—Lovastatin—coronary artery disease	7.41e-05	0.000548	CcSEcCtD
Perphenazine—Anorexia—Furosemide—coronary artery disease	7.39e-05	0.000547	CcSEcCtD
Perphenazine—Shock—Losartan—coronary artery disease	7.36e-05	0.000545	CcSEcCtD
Perphenazine—Constipation—Trandolapril—coronary artery disease	7.35e-05	0.000544	CcSEcCtD
Perphenazine—Urticaria—Valsartan—coronary artery disease	7.35e-05	0.000544	CcSEcCtD
Perphenazine—Decreased appetite—Telmisartan—coronary artery disease	7.34e-05	0.000544	CcSEcCtD
Perphenazine—Diarrhoea—Fenofibrate—coronary artery disease	7.34e-05	0.000543	CcSEcCtD
Perphenazine—Constipation—Enalapril—coronary artery disease	7.32e-05	0.000542	CcSEcCtD
Perphenazine—Dyspnoea—Captopril—coronary artery disease	7.32e-05	0.000542	CcSEcCtD
Perphenazine—Urticaria—Olmesartan—coronary artery disease	7.31e-05	0.000541	CcSEcCtD
Perphenazine—Somnolence—Captopril—coronary artery disease	7.3e-05	0.00054	CcSEcCtD
Perphenazine—Tachycardia—Losartan—coronary artery disease	7.3e-05	0.00054	CcSEcCtD
Perphenazine—Body temperature increased—Olmesartan—coronary artery disease	7.28e-05	0.000539	CcSEcCtD
Perphenazine—Pruritus—Ezetimibe—coronary artery disease	7.27e-05	0.000538	CcSEcCtD
Perphenazine—Hypotension—Furosemide—coronary artery disease	7.24e-05	0.000536	CcSEcCtD
Perphenazine—Vision blurred—Timolol—coronary artery disease	7.24e-05	0.000536	CcSEcCtD
Perphenazine—Pain—Telmisartan—coronary artery disease	7.22e-05	0.000535	CcSEcCtD
Perphenazine—Constipation—Telmisartan—coronary artery disease	7.22e-05	0.000535	CcSEcCtD
Perphenazine—Agitation—Ramipril—coronary artery disease	7.22e-05	0.000535	CcSEcCtD
Perphenazine—Hypersensitivity—Simvastatin—coronary artery disease	7.22e-05	0.000534	CcSEcCtD
Perphenazine—Insomnia—Perindopril—coronary artery disease	7.21e-05	0.000534	CcSEcCtD
Perphenazine—Diarrhoea—Clopidogrel—coronary artery disease	7.21e-05	0.000534	CcSEcCtD
Perphenazine—Angioedema—Ramipril—coronary artery disease	7.18e-05	0.000532	CcSEcCtD
Perphenazine—Diarrhoea—Lovastatin—coronary artery disease	7.16e-05	0.00053	CcSEcCtD
Perphenazine—Urticaria—Niacin—coronary artery disease	7.14e-05	0.000529	CcSEcCtD
Perphenazine—Decreased appetite—Captopril—coronary artery disease	7.14e-05	0.000529	CcSEcCtD
Perphenazine—Anorexia—Losartan—coronary artery disease	7.13e-05	0.000528	CcSEcCtD
Perphenazine—Erythema—Lisinopril—coronary artery disease	7.13e-05	0.000528	CcSEcCtD
Perphenazine—Pruritus—Eplerenone—coronary artery disease	7.11e-05	0.000526	CcSEcCtD
Perphenazine—Dyspnoea—Perindopril—coronary artery disease	7.11e-05	0.000526	CcSEcCtD
Perphenazine—Body temperature increased—Niacin—coronary artery disease	7.11e-05	0.000526	CcSEcCtD
Perphenazine—Dizziness—Fenofibrate—coronary artery disease	7.09e-05	0.000525	CcSEcCtD
Perphenazine—Somnolence—Perindopril—coronary artery disease	7.09e-05	0.000525	CcSEcCtD
Perphenazine—Syncope—Ramipril—coronary artery disease	7.05e-05	0.000522	CcSEcCtD
Perphenazine—Leukopenia—Ramipril—coronary artery disease	7.04e-05	0.000521	CcSEcCtD
Perphenazine—Urticaria—Pravastatin—coronary artery disease	7.03e-05	0.000521	CcSEcCtD
Perphenazine—Diarrhoea—Ezetimibe—coronary artery disease	7.03e-05	0.00052	CcSEcCtD
Perphenazine—Constipation—Captopril—coronary artery disease	7.02e-05	0.00052	CcSEcCtD
Perphenazine—Angioedema—Timolol—coronary artery disease	7.02e-05	0.00052	CcSEcCtD
Perphenazine—Body temperature increased—Pravastatin—coronary artery disease	7e-05	0.000518	CcSEcCtD
Perphenazine—Hypotension—Losartan—coronary artery disease	6.99e-05	0.000517	CcSEcCtD
Perphenazine—Dizziness—Clopidogrel—coronary artery disease	6.97e-05	0.000516	CcSEcCtD
Perphenazine—Decreased appetite—Perindopril—coronary artery disease	6.93e-05	0.000513	CcSEcCtD
Perphenazine—Pruritus—Simvastatin—coronary artery disease	6.93e-05	0.000513	CcSEcCtD
Perphenazine—Dizziness—Lovastatin—coronary artery disease	6.92e-05	0.000513	CcSEcCtD
Perphenazine—Loss of consciousness—Ramipril—coronary artery disease	6.91e-05	0.000511	CcSEcCtD
Perphenazine—Somnolence—Furosemide—coronary artery disease	6.89e-05	0.00051	CcSEcCtD
Perphenazine—Syncope—Timolol—coronary artery disease	6.89e-05	0.00051	CcSEcCtD
Perphenazine—Diarrhoea—Eplerenone—coronary artery disease	6.88e-05	0.000509	CcSEcCtD
Perphenazine—Cough—Ramipril—coronary artery disease	6.86e-05	0.000508	CcSEcCtD
Perphenazine—Muscle spasms—Lisinopril—coronary artery disease	6.85e-05	0.000507	CcSEcCtD
Perphenazine—Urticaria—Trandolapril—coronary artery disease	6.83e-05	0.000506	CcSEcCtD
Perphenazine—Pain—Perindopril—coronary artery disease	6.82e-05	0.000505	CcSEcCtD
Perphenazine—Constipation—Perindopril—coronary artery disease	6.82e-05	0.000505	CcSEcCtD
Perphenazine—Hypersensitivity—Valsartan—coronary artery disease	6.81e-05	0.000504	CcSEcCtD
Perphenazine—Convulsion—Ramipril—coronary artery disease	6.81e-05	0.000504	CcSEcCtD
Perphenazine—Urticaria—Enalapril—coronary artery disease	6.8e-05	0.000504	CcSEcCtD
Perphenazine—Body temperature increased—Trandolapril—coronary artery disease	6.8e-05	0.000503	CcSEcCtD
Perphenazine—Dizziness—Ezetimibe—coronary artery disease	6.79e-05	0.000503	CcSEcCtD
Perphenazine—Body temperature increased—Enalapril—coronary artery disease	6.77e-05	0.000501	CcSEcCtD
Perphenazine—Insomnia—Losartan—coronary artery disease	6.77e-05	0.000501	CcSEcCtD
Perphenazine—Loss of consciousness—Timolol—coronary artery disease	6.75e-05	0.0005	CcSEcCtD
Perphenazine—Decreased appetite—Furosemide—coronary artery disease	6.74e-05	0.000499	CcSEcCtD
Perphenazine—Headache—Fenofibrate—coronary artery disease	6.72e-05	0.000497	CcSEcCtD
Perphenazine—Vision blurred—Lisinopril—coronary artery disease	6.72e-05	0.000497	CcSEcCtD
Perphenazine—Urticaria—Telmisartan—coronary artery disease	6.71e-05	0.000497	CcSEcCtD
Perphenazine—Cough—Timolol—coronary artery disease	6.7e-05	0.000496	CcSEcCtD
Perphenazine—Quetiapine—HTR7—coronary artery disease	6.7e-05	0.0303	CrCbGaD
Perphenazine—Diarrhoea—Simvastatin—coronary artery disease	6.7e-05	0.000496	CcSEcCtD
Perphenazine—Body temperature increased—Telmisartan—coronary artery disease	6.68e-05	0.000494	CcSEcCtD
Perphenazine—Dyspnoea—Losartan—coronary artery disease	6.67e-05	0.000494	CcSEcCtD
Perphenazine—Somnolence—Losartan—coronary artery disease	6.65e-05	0.000492	CcSEcCtD
Perphenazine—Dizziness—Eplerenone—coronary artery disease	6.65e-05	0.000492	CcSEcCtD
Perphenazine—Hypertension—Timolol—coronary artery disease	6.63e-05	0.000491	CcSEcCtD
Perphenazine—Constipation—Furosemide—coronary artery disease	6.63e-05	0.000491	CcSEcCtD
Perphenazine—Pain—Furosemide—coronary artery disease	6.63e-05	0.000491	CcSEcCtD
Perphenazine—Hypersensitivity—Niacin—coronary artery disease	6.63e-05	0.00049	CcSEcCtD
Perphenazine—Headache—Clopidogrel—coronary artery disease	6.6e-05	0.000489	CcSEcCtD
Perphenazine—Headache—Lovastatin—coronary artery disease	6.56e-05	0.000486	CcSEcCtD
Perphenazine—Pruritus—Valsartan—coronary artery disease	6.54e-05	0.000484	CcSEcCtD
Perphenazine—Dry mouth—Ramipril—coronary artery disease	6.54e-05	0.000484	CcSEcCtD
Perphenazine—Hypersensitivity—Pravastatin—coronary artery disease	6.52e-05	0.000483	CcSEcCtD
Perphenazine—Angioedema—Lisinopril—coronary artery disease	6.51e-05	0.000482	CcSEcCtD
Perphenazine—Pruritus—Olmesartan—coronary artery disease	6.51e-05	0.000482	CcSEcCtD
Perphenazine—Decreased appetite—Losartan—coronary artery disease	6.5e-05	0.000481	CcSEcCtD
Perphenazine—Body temperature increased—Captopril—coronary artery disease	6.49e-05	0.000481	CcSEcCtD
Perphenazine—Dizziness—Simvastatin—coronary artery disease	6.48e-05	0.000479	CcSEcCtD
Perphenazine—Confusional state—Ramipril—coronary artery disease	6.47e-05	0.000479	CcSEcCtD
Perphenazine—Headache—Ezetimibe—coronary artery disease	6.43e-05	0.000476	CcSEcCtD
Perphenazine—Anaphylactic shock—Ramipril—coronary artery disease	6.41e-05	0.000475	CcSEcCtD
Perphenazine—Dry mouth—Timolol—coronary artery disease	6.4e-05	0.000474	CcSEcCtD
Perphenazine—Pain—Losartan—coronary artery disease	6.4e-05	0.000473	CcSEcCtD
Perphenazine—Constipation—Losartan—coronary artery disease	6.4e-05	0.000473	CcSEcCtD
Perphenazine—Syncope—Lisinopril—coronary artery disease	6.39e-05	0.000473	CcSEcCtD
Perphenazine—Leukopenia—Lisinopril—coronary artery disease	6.38e-05	0.000472	CcSEcCtD
Perphenazine—Pruritus—Niacin—coronary artery disease	6.36e-05	0.000471	CcSEcCtD
Perphenazine—Urticaria—Perindopril—coronary artery disease	6.34e-05	0.000469	CcSEcCtD
Perphenazine—Hypersensitivity—Trandolapril—coronary artery disease	6.34e-05	0.000469	CcSEcCtD
Perphenazine—Diarrhoea—Valsartan—coronary artery disease	6.33e-05	0.000468	CcSEcCtD
Perphenazine—Confusional state—Timolol—coronary artery disease	6.32e-05	0.000468	CcSEcCtD
Perphenazine—Shock—Ramipril—coronary artery disease	6.31e-05	0.000467	CcSEcCtD
Perphenazine—Hypersensitivity—Enalapril—coronary artery disease	6.31e-05	0.000467	CcSEcCtD
Perphenazine—Body temperature increased—Perindopril—coronary artery disease	6.3e-05	0.000467	CcSEcCtD
Perphenazine—Diarrhoea—Olmesartan—coronary artery disease	6.3e-05	0.000466	CcSEcCtD
Perphenazine—Headache—Eplerenone—coronary artery disease	6.3e-05	0.000466	CcSEcCtD
Perphenazine—Anaphylactic shock—Timolol—coronary artery disease	6.27e-05	0.000464	CcSEcCtD
Perphenazine—Pruritus—Pravastatin—coronary artery disease	6.26e-05	0.000464	CcSEcCtD
Perphenazine—Loss of consciousness—Lisinopril—coronary artery disease	6.26e-05	0.000464	CcSEcCtD
Perphenazine—Tachycardia—Ramipril—coronary artery disease	6.26e-05	0.000463	CcSEcCtD
Perphenazine—Infection—Timolol—coronary artery disease	6.23e-05	0.000461	CcSEcCtD
Perphenazine—Hypersensitivity—Telmisartan—coronary artery disease	6.22e-05	0.000461	CcSEcCtD
Perphenazine—Cough—Lisinopril—coronary artery disease	6.22e-05	0.00046	CcSEcCtD
Perphenazine—Pipotiazine—CYP2C19—coronary artery disease	6.2e-05	0.0281	CrCbGaD
Perphenazine—Shock—Timolol—coronary artery disease	6.17e-05	0.000457	CcSEcCtD
Perphenazine—Urticaria—Furosemide—coronary artery disease	6.16e-05	0.000456	CcSEcCtD
Perphenazine—Diarrhoea—Niacin—coronary artery disease	6.15e-05	0.000455	CcSEcCtD
Perphenazine—Headache—Simvastatin—coronary artery disease	6.14e-05	0.000454	CcSEcCtD
Perphenazine—Body temperature increased—Furosemide—coronary artery disease	6.13e-05	0.000454	CcSEcCtD
Perphenazine—Dizziness—Valsartan—coronary artery disease	6.12e-05	0.000453	CcSEcCtD
Perphenazine—Anorexia—Ramipril—coronary artery disease	6.11e-05	0.000453	CcSEcCtD
Perphenazine—Dizziness—Olmesartan—coronary artery disease	6.09e-05	0.000451	CcSEcCtD
Perphenazine—Pruritus—Trandolapril—coronary artery disease	6.08e-05	0.00045	CcSEcCtD
Perphenazine—Pruritus—Enalapril—coronary artery disease	6.06e-05	0.000448	CcSEcCtD
Perphenazine—Diarrhoea—Pravastatin—coronary artery disease	6.06e-05	0.000448	CcSEcCtD
Perphenazine—Hypotension—Ramipril—coronary artery disease	5.99e-05	0.000444	CcSEcCtD
Perphenazine—Anorexia—Timolol—coronary artery disease	5.98e-05	0.000442	CcSEcCtD
Perphenazine—Pruritus—Telmisartan—coronary artery disease	5.98e-05	0.000442	CcSEcCtD
Perphenazine—Dizziness—Niacin—coronary artery disease	5.95e-05	0.00044	CcSEcCtD
Perphenazine—Urticaria—Losartan—coronary artery disease	5.94e-05	0.00044	CcSEcCtD
Perphenazine—Dry mouth—Lisinopril—coronary artery disease	5.93e-05	0.000439	CcSEcCtD
Perphenazine—Body temperature increased—Losartan—coronary artery disease	5.91e-05	0.000438	CcSEcCtD
Perphenazine—Diarrhoea—Trandolapril—coronary artery disease	5.88e-05	0.000435	CcSEcCtD
Perphenazine—Confusional state—Lisinopril—coronary artery disease	5.87e-05	0.000434	CcSEcCtD
Perphenazine—Diarrhoea—Enalapril—coronary artery disease	5.86e-05	0.000434	CcSEcCtD
Perphenazine—Hypotension—Timolol—coronary artery disease	5.86e-05	0.000434	CcSEcCtD
Perphenazine—Dizziness—Pravastatin—coronary artery disease	5.86e-05	0.000433	CcSEcCtD
Perphenazine—Zuclopenthixol—HTR2A—coronary artery disease	5.83e-05	0.0264	CrCbGaD
Perphenazine—Anaphylactic shock—Lisinopril—coronary artery disease	5.82e-05	0.000431	CcSEcCtD
Perphenazine—Pruritus—Captopril—coronary artery disease	5.81e-05	0.00043	CcSEcCtD
Perphenazine—Insomnia—Ramipril—coronary artery disease	5.8e-05	0.000429	CcSEcCtD
Perphenazine—Nefazodone—HTR2A—coronary artery disease	5.8e-05	0.0263	CrCbGaD
Perphenazine—Headache—Valsartan—coronary artery disease	5.79e-05	0.000429	CcSEcCtD
Perphenazine—Diarrhoea—Telmisartan—coronary artery disease	5.78e-05	0.000428	CcSEcCtD
Perphenazine—Infection—Lisinopril—coronary artery disease	5.78e-05	0.000428	CcSEcCtD
Perphenazine—Headache—Olmesartan—coronary artery disease	5.77e-05	0.000427	CcSEcCtD
Perphenazine—Shock—Lisinopril—coronary artery disease	5.72e-05	0.000424	CcSEcCtD
Perphenazine—Dyspnoea—Ramipril—coronary artery disease	5.72e-05	0.000423	CcSEcCtD
Perphenazine—Hypersensitivity—Furosemide—coronary artery disease	5.71e-05	0.000423	CcSEcCtD
Perphenazine—Somnolence—Ramipril—coronary artery disease	5.7e-05	0.000422	CcSEcCtD
Perphenazine—Dizziness—Trandolapril—coronary artery disease	5.69e-05	0.000421	CcSEcCtD
Perphenazine—Tachycardia—Lisinopril—coronary artery disease	5.68e-05	0.00042	CcSEcCtD
Perphenazine—Insomnia—Timolol—coronary artery disease	5.67e-05	0.00042	CcSEcCtD
Perphenazine—Dizziness—Enalapril—coronary artery disease	5.66e-05	0.000419	CcSEcCtD
Perphenazine—Pruritus—Perindopril—coronary artery disease	5.64e-05	0.000418	CcSEcCtD
Perphenazine—Headache—Niacin—coronary artery disease	5.63e-05	0.000417	CcSEcCtD
Perphenazine—Diarrhoea—Captopril—coronary artery disease	5.62e-05	0.000416	CcSEcCtD
Perphenazine—Dyspnoea—Timolol—coronary artery disease	5.59e-05	0.000414	CcSEcCtD
Perphenazine—Dizziness—Telmisartan—coronary artery disease	5.59e-05	0.000413	CcSEcCtD
Perphenazine—Decreased appetite—Ramipril—coronary artery disease	5.58e-05	0.000413	CcSEcCtD
Perphenazine—Somnolence—Timolol—coronary artery disease	5.57e-05	0.000413	CcSEcCtD
Perphenazine—Headache—Pravastatin—coronary artery disease	5.55e-05	0.000411	CcSEcCtD
Perphenazine—Anorexia—Lisinopril—coronary artery disease	5.55e-05	0.00041	CcSEcCtD
Perphenazine—Hypersensitivity—Losartan—coronary artery disease	5.51e-05	0.000408	CcSEcCtD
Perphenazine—Pruritus—Furosemide—coronary artery disease	5.49e-05	0.000406	CcSEcCtD
Perphenazine—Constipation—Ramipril—coronary artery disease	5.49e-05	0.000406	CcSEcCtD
Perphenazine—Diarrhoea—Perindopril—coronary artery disease	5.46e-05	0.000404	CcSEcCtD
Perphenazine—Decreased appetite—Timolol—coronary artery disease	5.45e-05	0.000403	CcSEcCtD
Perphenazine—Hypotension—Lisinopril—coronary artery disease	5.44e-05	0.000402	CcSEcCtD
Perphenazine—Dizziness—Captopril—coronary artery disease	5.43e-05	0.000402	CcSEcCtD
Perphenazine—Chlorpromazine—HTR7—coronary artery disease	5.42e-05	0.0245	CrCbGaD
Perphenazine—Aripiprazole—HTR2A—coronary artery disease	5.39e-05	0.0244	CrCbGaD
Perphenazine—Headache—Trandolapril—coronary artery disease	5.39e-05	0.000399	CcSEcCtD
Perphenazine—Trazodone—HTR2A—coronary artery disease	5.37e-05	0.0243	CrCbGaD
Perphenazine—Headache—Enalapril—coronary artery disease	5.37e-05	0.000397	CcSEcCtD
Perphenazine—Pain—Timolol—coronary artery disease	5.36e-05	0.000397	CcSEcCtD
Perphenazine—Diarrhoea—Furosemide—coronary artery disease	5.3e-05	0.000393	CcSEcCtD
Perphenazine—Pruritus—Losartan—coronary artery disease	5.29e-05	0.000392	CcSEcCtD
Perphenazine—Headache—Telmisartan—coronary artery disease	5.29e-05	0.000392	CcSEcCtD
Perphenazine—Dizziness—Perindopril—coronary artery disease	5.27e-05	0.00039	CcSEcCtD
Perphenazine—Insomnia—Lisinopril—coronary artery disease	5.26e-05	0.000389	CcSEcCtD
Perphenazine—Acepromazine—HTR2A—coronary artery disease	5.23e-05	0.0237	CrCbGaD
Perphenazine—Dyspnoea—Lisinopril—coronary artery disease	5.19e-05	0.000384	CcSEcCtD
Perphenazine—Somnolence—Lisinopril—coronary artery disease	5.17e-05	0.000383	CcSEcCtD
Perphenazine—Headache—Captopril—coronary artery disease	5.15e-05	0.000381	CcSEcCtD
Perphenazine—Dizziness—Furosemide—coronary artery disease	5.13e-05	0.000379	CcSEcCtD
Perphenazine—Diarrhoea—Losartan—coronary artery disease	5.12e-05	0.000379	CcSEcCtD
Perphenazine—Thioproperazine—HTR2A—coronary artery disease	5.11e-05	0.0231	CrCbGaD
Perphenazine—Urticaria—Ramipril—coronary artery disease	5.1e-05	0.000377	CcSEcCtD
Perphenazine—Body temperature increased—Ramipril—coronary artery disease	5.07e-05	0.000375	CcSEcCtD
Perphenazine—Decreased appetite—Lisinopril—coronary artery disease	5.06e-05	0.000374	CcSEcCtD
Perphenazine—Thiothixene—HTR2A—coronary artery disease	5.03e-05	0.0228	CrCbGaD
Perphenazine—Pipotiazine—HTR2A—coronary artery disease	5.03e-05	0.0228	CrCbGaD
Perphenazine—Headache—Perindopril—coronary artery disease	5e-05	0.00037	CcSEcCtD
Perphenazine—Urticaria—Timolol—coronary artery disease	4.98e-05	0.000369	CcSEcCtD
Perphenazine—Pain—Lisinopril—coronary artery disease	4.97e-05	0.000368	CcSEcCtD
Perphenazine—Constipation—Lisinopril—coronary artery disease	4.97e-05	0.000368	CcSEcCtD
Perphenazine—Mesoridazine—HTR2A—coronary artery disease	4.96e-05	0.0225	CrCbGaD
Perphenazine—Body temperature increased—Timolol—coronary artery disease	4.96e-05	0.000367	CcSEcCtD
Perphenazine—Dizziness—Losartan—coronary artery disease	4.95e-05	0.000366	CcSEcCtD
Perphenazine—Clomipramine—CYP2C19—coronary artery disease	4.9e-05	0.0222	CrCbGaD
Perphenazine—Headache—Furosemide—coronary artery disease	4.86e-05	0.000359	CcSEcCtD
Perphenazine—Hypersensitivity—Ramipril—coronary artery disease	4.73e-05	0.00035	CcSEcCtD
Perphenazine—Headache—Losartan—coronary artery disease	4.69e-05	0.000347	CcSEcCtD
Perphenazine—Urticaria—Lisinopril—coronary artery disease	4.62e-05	0.000342	CcSEcCtD
Perphenazine—Hypersensitivity—Timolol—coronary artery disease	4.62e-05	0.000342	CcSEcCtD
Perphenazine—Thioridazine—CYP2C19—coronary artery disease	4.62e-05	0.0209	CrCbGaD
Perphenazine—Body temperature increased—Lisinopril—coronary artery disease	4.6e-05	0.00034	CcSEcCtD
Perphenazine—Pruritus—Ramipril—coronary artery disease	4.54e-05	0.000336	CcSEcCtD
Perphenazine—Pruritus—Timolol—coronary artery disease	4.44e-05	0.000328	CcSEcCtD
Perphenazine—Diarrhoea—Ramipril—coronary artery disease	4.39e-05	0.000325	CcSEcCtD
Perphenazine—Fluphenazine—HTR2A—coronary artery disease	4.35e-05	0.0197	CrCbGaD
Perphenazine—Diarrhoea—Timolol—coronary artery disease	4.29e-05	0.000318	CcSEcCtD
Perphenazine—Hypersensitivity—Lisinopril—coronary artery disease	4.29e-05	0.000317	CcSEcCtD
Perphenazine—Dizziness—Ramipril—coronary artery disease	4.24e-05	0.000314	CcSEcCtD
Perphenazine—Propiomazine—HTR2A—coronary artery disease	4.18e-05	0.0189	CrCbGaD
Perphenazine—Quetiapine—CYP2C19—coronary artery disease	4.16e-05	0.0188	CrCbGaD
Perphenazine—Dizziness—Timolol—coronary artery disease	4.15e-05	0.000307	CcSEcCtD
Perphenazine—Pruritus—Lisinopril—coronary artery disease	4.12e-05	0.000305	CcSEcCtD
Perphenazine—Headache—Ramipril—coronary artery disease	4.02e-05	0.000297	CcSEcCtD
Perphenazine—Diarrhoea—Lisinopril—coronary artery disease	3.98e-05	0.000295	CcSEcCtD
Perphenazine—Clomipramine—HTR2A—coronary artery disease	3.97e-05	0.018	CrCbGaD
Perphenazine—Chlorprothixene—HTR2A—coronary artery disease	3.96e-05	0.0179	CrCbGaD
Perphenazine—Headache—Timolol—coronary artery disease	3.93e-05	0.000291	CcSEcCtD
Perphenazine—Dizziness—Lisinopril—coronary artery disease	3.85e-05	0.000285	CcSEcCtD
Perphenazine—Promazine—CYP2C19—coronary artery disease	3.82e-05	0.0173	CrCbGaD
Perphenazine—Thioridazine—HTR2A—coronary artery disease	3.74e-05	0.017	CrCbGaD
Perphenazine—Headache—Lisinopril—coronary artery disease	3.64e-05	0.00027	CcSEcCtD
Perphenazine—Acepromazine—ALB—coronary artery disease	3.58e-05	0.0162	CrCbGaD
Perphenazine—Methotrimeprazine—HTR2A—coronary artery disease	3.57e-05	0.0162	CrCbGaD
Perphenazine—Promethazine—HTR2A—coronary artery disease	3.52e-05	0.0159	CrCbGaD
Perphenazine—Thioproperazine—ALB—coronary artery disease	3.5e-05	0.0158	CrCbGaD
Perphenazine—Trifluoperazine—HTR2A—coronary artery disease	3.47e-05	0.0157	CrCbGaD
Perphenazine—Thiothixene—ALB—coronary artery disease	3.44e-05	0.0156	CrCbGaD
Perphenazine—Pipotiazine—ALB—coronary artery disease	3.44e-05	0.0156	CrCbGaD
Perphenazine—Quetiapine—HTR2A—coronary artery disease	3.37e-05	0.0153	CrCbGaD
Perphenazine—Promazine—HTR2A—coronary artery disease	3.1e-05	0.014	CrCbGaD
Perphenazine—Chlorpromazine—HTR2A—coronary artery disease	2.73e-05	0.0123	CrCbGaD
Perphenazine—Clomipramine—ALB—coronary artery disease	2.72e-05	0.0123	CrCbGaD
Perphenazine—Chlorpromazine—ALB—coronary artery disease	1.87e-05	0.00845	CrCbGaD
Perphenazine—ADRA2A—Signaling Pathways—FGF2—coronary artery disease	8.73e-07	7.13e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—POMC—coronary artery disease	8.71e-07	7.12e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—POMC—coronary artery disease	8.71e-07	7.12e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CREB1—coronary artery disease	8.71e-07	7.12e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CREB1—coronary artery disease	8.71e-07	7.12e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IGF1—coronary artery disease	8.67e-07	7.08e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—MAPK1—coronary artery disease	8.62e-07	7.04e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GGT1—coronary artery disease	8.62e-07	7.04e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GOT1—coronary artery disease	8.62e-07	7.04e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NOS3—coronary artery disease	8.61e-07	7.03e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CD36—coronary artery disease	8.6e-07	7.03e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—coronary artery disease	8.59e-07	7.02e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—ALB—coronary artery disease	8.54e-07	6.98e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CXCL8—coronary artery disease	8.53e-07	6.97e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCL2—coronary artery disease	8.53e-07	6.96e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCL2—coronary artery disease	8.53e-07	6.96e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	8.53e-07	6.96e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6R—coronary artery disease	8.5e-07	6.94e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6R—coronary artery disease	8.5e-07	6.94e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPP2CA—coronary artery disease	8.49e-07	6.94e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PPARG—coronary artery disease	8.48e-07	6.93e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—AKT1—coronary artery disease	8.48e-07	6.93e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TGFB1—coronary artery disease	8.42e-07	6.88e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.41e-07	6.87e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CXCL8—coronary artery disease	8.4e-07	6.86e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IGF1—coronary artery disease	8.38e-07	6.85e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IGF1—coronary artery disease	8.38e-07	6.85e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CXCL8—coronary artery disease	8.38e-07	6.84e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—JAK2—coronary artery disease	8.37e-07	6.84e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—POMC—coronary artery disease	8.37e-07	6.83e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—MAPK1—coronary artery disease	8.34e-07	6.81e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—MAPK1—coronary artery disease	8.34e-07	6.81e-06	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—PIK3CA—coronary artery disease	8.33e-07	6.8e-06	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—PIK3CA—coronary artery disease	8.32e-07	6.79e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—coronary artery disease	8.31e-07	6.79e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—coronary artery disease	8.31e-07	6.79e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MAPK1—coronary artery disease	8.26e-07	6.75e-06	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—AKT1—coronary artery disease	8.24e-07	6.73e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SERPINE1—coronary artery disease	8.23e-07	6.72e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—PIK3CA—coronary artery disease	8.2e-07	6.7e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—NOS3—coronary artery disease	8.17e-07	6.68e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CASP3—coronary artery disease	8.17e-07	6.67e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—MTHFR—coronary artery disease	8.15e-07	6.66e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—IL6—coronary artery disease	8.11e-07	6.63e-06	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—AKT1—coronary artery disease	8.11e-07	6.62e-06	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—AKT1—coronary artery disease	8.09e-07	6.61e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CASP3—coronary artery disease	8.04e-07	6.56e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CASP3—coronary artery disease	8.02e-07	6.55e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—IL6—coronary artery disease	7.98e-07	6.52e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—FGF2—coronary artery disease	7.97e-07	6.51e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—IL6—coronary artery disease	7.97e-07	6.51e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SERPINE1—coronary artery disease	7.96e-07	6.5e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SERPINE1—coronary artery disease	7.96e-07	6.5e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCND1—coronary artery disease	7.95e-07	6.49e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	7.89e-07	6.45e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—MAPK1—coronary artery disease	7.88e-07	6.44e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NOS3—coronary artery disease	7.86e-07	6.42e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—coronary artery disease	7.85e-07	6.41e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCND1—coronary artery disease	7.82e-07	6.39e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCND1—coronary artery disease	7.8e-07	6.37e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PPARG—coronary artery disease	7.8e-07	6.37e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTP1—coronary artery disease	7.75e-07	6.33e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AGT—coronary artery disease	7.74e-07	6.33e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PPARG—coronary artery disease	7.73e-07	6.32e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MMP9—coronary artery disease	7.72e-07	6.3e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—FGF2—coronary artery disease	7.71e-07	6.29e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—FGF2—coronary artery disease	7.71e-07	6.29e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—POMC—coronary artery disease	7.69e-07	6.28e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	7.67e-07	6.27e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—HMOX1—coronary artery disease	7.64e-07	6.24e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CXCL8—coronary artery disease	7.64e-07	6.24e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—JAK2—coronary artery disease	7.64e-07	6.24e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—POMC—coronary artery disease	7.63e-07	6.23e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—ALB—coronary artery disease	7.63e-07	6.23e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—MAPK1—coronary artery disease	7.62e-07	6.23e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—MAPK1—coronary artery disease	7.62e-07	6.23e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NOS3—coronary artery disease	7.6e-07	6.21e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NOS3—coronary artery disease	7.6e-07	6.21e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP9—coronary artery disease	7.59e-07	6.2e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—APOE—coronary artery disease	7.59e-07	6.2e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP9—coronary artery disease	7.58e-07	6.19e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CAT—coronary artery disease	7.54e-07	6.16e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—APOA1—coronary artery disease	7.5e-07	6.13e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—AKT1—coronary artery disease	7.49e-07	6.11e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—PIK3CA—coronary artery disease	7.48e-07	6.11e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—coronary artery disease	7.48e-07	6.11e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFB1—coronary artery disease	7.42e-07	6.06e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—JAK2—coronary artery disease	7.39e-07	6.03e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—JAK2—coronary artery disease	7.39e-07	6.03e-06	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—AKT1—coronary artery disease	7.38e-07	6.03e-06	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—IL6—coronary artery disease	7.37e-07	6.02e-06	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—IL6—coronary artery disease	7.37e-07	6.02e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—AKT1—coronary artery disease	7.36e-07	6.02e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—AKT1—coronary artery disease	7.35e-07	6e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOB—coronary artery disease	7.32e-07	5.98e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CASP3—coronary artery disease	7.31e-07	5.97e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—NOS3—coronary artery disease	7.3e-07	5.96e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—MAPK1—coronary artery disease	7.28e-07	5.94e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—IL6—coronary artery disease	7.26e-07	5.93e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	7.24e-07	5.92e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PIK3CA—coronary artery disease	7.24e-07	5.91e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PIK3CA—coronary artery disease	7.24e-07	5.91e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—coronary artery disease	7.21e-07	5.89e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.18e-07	5.87e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—coronary artery disease	7.18e-07	5.86e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—coronary artery disease	7.18e-07	5.86e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—coronary artery disease	7.17e-07	5.86e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTM1—coronary artery disease	7.12e-07	5.81e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—coronary artery disease	7.12e-07	5.81e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	7.1e-07	5.8e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MAPK1—coronary artery disease	7.07e-07	5.77e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—MAPK1—coronary artery disease	7.04e-07	5.75e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—MAPK1—coronary artery disease	7.04e-07	5.75e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—ALB—coronary artery disease	7.02e-07	5.73e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—LPL—coronary artery disease	6.99e-07	5.71e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CXCL8—coronary artery disease	6.97e-07	5.69e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—ALB—coronary artery disease	6.95e-07	5.68e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—coronary artery disease	6.93e-07	5.66e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—coronary artery disease	6.91e-07	5.64e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—coronary artery disease	6.84e-07	5.59e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—coronary artery disease	6.82e-07	5.57e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GPX1—coronary artery disease	6.82e-07	5.57e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—coronary artery disease	6.8e-07	5.56e-06	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—AKT1—coronary artery disease	6.8e-07	5.56e-06	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—AKT1—coronary artery disease	6.8e-07	5.55e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CXCL8—coronary artery disease	6.74e-07	5.51e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CXCL8—coronary artery disease	6.74e-07	5.51e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—NOS3—coronary artery disease	6.71e-07	5.48e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—AKT1—coronary artery disease	6.7e-07	5.47e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—coronary artery disease	6.67e-07	5.45e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CASP3—coronary artery disease	6.67e-07	5.45e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—NOS3—coronary artery disease	6.65e-07	5.43e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CD36—coronary artery disease	6.64e-07	5.42e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—IL6—coronary artery disease	6.63e-07	5.41e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—coronary artery disease	6.61e-07	5.4e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—coronary artery disease	6.61e-07	5.4e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PPARG—coronary artery disease	6.61e-07	5.4e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPP2CA—coronary artery disease	6.55e-07	5.35e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—POMC—coronary artery disease	6.52e-07	5.32e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—coronary artery disease	6.49e-07	5.3e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CASP3—coronary artery disease	6.45e-07	5.27e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CASP3—coronary artery disease	6.45e-07	5.27e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—IL6—coronary artery disease	6.41e-07	5.24e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—IL6—coronary artery disease	6.41e-07	5.24e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—coronary artery disease	6.36e-07	5.2e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—IL6—coronary artery disease	6.35e-07	5.19e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—coronary artery disease	6.31e-07	5.16e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—coronary artery disease	6.3e-07	5.15e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—MTHFR—coronary artery disease	6.29e-07	5.14e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—coronary artery disease	6.28e-07	5.13e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—coronary artery disease	6.28e-07	5.13e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—coronary artery disease	6.26e-07	5.11e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—coronary artery disease	6.25e-07	5.1e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK1—coronary artery disease	6.24e-07	5.09e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—coronary artery disease	6.2e-07	5.07e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	6.16e-07	5.04e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK1—coronary artery disease	6.14e-07	5.01e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—coronary artery disease	6.14e-07	5.01e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—coronary artery disease	6.13e-07	5.01e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK1—coronary artery disease	6.12e-07	5e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—AKT1—coronary artery disease	6.11e-07	4.99e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—coronary artery disease	6.11e-07	4.99e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—coronary artery disease	6.11e-07	4.99e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—coronary artery disease	6.1e-07	4.98e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—coronary artery disease	6.1e-07	4.98e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—coronary artery disease	6.08e-07	4.97e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL6—coronary artery disease	6.06e-07	4.95e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AGT—coronary artery disease	5.98e-07	4.88e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—ALB—coronary artery disease	5.94e-07	4.85e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—AKT1—coronary artery disease	5.91e-07	4.83e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—AKT1—coronary artery disease	5.91e-07	4.83e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL6—coronary artery disease	5.86e-07	4.78e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL6—coronary artery disease	5.86e-07	4.78e-06	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—AKT1—coronary artery disease	5.86e-07	4.78e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOE—coronary artery disease	5.86e-07	4.78e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—coronary artery disease	5.79e-07	4.73e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—APOA1—coronary artery disease	5.79e-07	4.73e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—coronary artery disease	5.69e-07	4.65e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—NOS3—coronary artery disease	5.68e-07	4.64e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—coronary artery disease	5.66e-07	4.62e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—IL6—coronary artery disease	5.59e-07	4.57e-06	CbGpPWpGaD
Perphenazine—CALM3—Immune System—AKT1—coronary artery disease	5.59e-07	4.56e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK1—coronary artery disease	5.58e-07	4.56e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—coronary artery disease	5.48e-07	4.47e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—coronary artery disease	5.48e-07	4.47e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—IL6—coronary artery disease	5.46e-07	4.46e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—coronary artery disease	5.43e-07	4.44e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—IL6—coronary artery disease	5.43e-07	4.44e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—coronary artery disease	5.41e-07	4.42e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—IL6—coronary artery disease	5.41e-07	4.42e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—IL6—coronary artery disease	5.41e-07	4.42e-06	CbGpPWpGaD
Perphenazine—CALM2—Immune System—AKT1—coronary artery disease	5.4e-07	4.41e-06	CbGpPWpGaD
Perphenazine—CALM1—Immune System—AKT1—coronary artery disease	5.4e-07	4.41e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—coronary artery disease	5.33e-07	4.35e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—coronary artery disease	5.31e-07	4.34e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—coronary artery disease	5.29e-07	4.32e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—coronary artery disease	5.2e-07	4.25e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—coronary artery disease	5.2e-07	4.24e-06	CbGpPWpGaD
Perphenazine—CALM3—Disease—AKT1—coronary artery disease	5.16e-07	4.21e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—coronary artery disease	5.11e-07	4.18e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—coronary artery disease	5.11e-07	4.18e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PPARG—coronary artery disease	5.1e-07	4.17e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK1—coronary artery disease	5.09e-07	4.16e-06	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—AKT1—coronary artery disease	5.04e-07	4.11e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—POMC—coronary artery disease	5.03e-07	4.11e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—coronary artery disease	5.03e-07	4.1e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—coronary artery disease	5.03e-07	4.1e-06	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—AKT1—coronary artery disease	5.01e-07	4.09e-06	CbGpPWpGaD
Perphenazine—CALM1—Disease—AKT1—coronary artery disease	4.99e-07	4.07e-06	CbGpPWpGaD
Perphenazine—CALM2—Disease—AKT1—coronary artery disease	4.99e-07	4.07e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK1—coronary artery disease	4.93e-07	4.03e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK1—coronary artery disease	4.93e-07	4.03e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—coronary artery disease	4.85e-07	3.96e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL6—coronary artery disease	4.79e-07	3.91e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—AKT1—coronary artery disease	4.73e-07	3.87e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL6—coronary artery disease	4.72e-07	3.85e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL6—coronary artery disease	4.71e-07	3.84e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—coronary artery disease	4.6e-07	3.76e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ALB—coronary artery disease	4.59e-07	3.75e-06	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—AKT1—coronary artery disease	4.44e-07	3.62e-06	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—AKT1—coronary artery disease	4.42e-07	3.61e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—coronary artery disease	4.42e-07	3.61e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—NOS3—coronary artery disease	4.39e-07	3.58e-06	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—AKT1—coronary artery disease	4.35e-07	3.55e-06	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—AKT1—coronary artery disease	4.34e-07	3.55e-06	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—AKT1—coronary artery disease	4.32e-07	3.53e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL6—coronary artery disease	4.29e-07	3.5e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—coronary artery disease	4.28e-07	3.49e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—coronary artery disease	4.28e-07	3.49e-06	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—AKT1—coronary artery disease	4.18e-07	3.41e-06	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—AKT1—coronary artery disease	4.18e-07	3.41e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—coronary artery disease	4.11e-07	3.35e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.01e-07	3.28e-06	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—AKT1—coronary artery disease	3.96e-07	3.23e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL6—coronary artery disease	3.91e-07	3.2e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL6—coronary artery disease	3.79e-07	3.09e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL6—coronary artery disease	3.79e-07	3.09e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	3.78e-07	3.08e-06	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—AKT1—coronary artery disease	3.76e-07	3.07e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	3.74e-07	3.06e-06	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—AKT1—coronary artery disease	3.61e-07	2.95e-06	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—AKT1—coronary artery disease	3.49e-07	2.85e-06	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—AKT1—coronary artery disease	3.49e-07	2.85e-06	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—AKT1—coronary artery disease	3.35e-07	2.74e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—coronary artery disease	3.2e-07	2.61e-06	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—AKT1—coronary artery disease	3.08e-07	2.52e-06	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—AKT1—coronary artery disease	3.06e-07	2.5e-06	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—AKT1—coronary artery disease	2.61e-07	2.13e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.47e-07	2.02e-06	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—AKT1—coronary artery disease	2.02e-07	1.65e-06	CbGpPWpGaD
